This week, many public offering investigations A -share listed companies, Yinhua Fund Investigation Science and Technology News

On July 1, Capital State learned that this week (June 27-July 1, the same below), many public funds frequently investigated A-share listed companies.

Rhein Biological (002166.SZ) disclosed the latest investor relationship record records today. The announcement shows that from June 29th to 30th, 2022, the Red Earth Innovation Fund, the National Lian'an Fund, Huaxia Fund, Galaxy Fund, Fuanda Fund, and Southern Ruitai Fund, Chunhou Fund, and Huashang Fund and other institutions have started online surveys, mainly focusing on the progress of industrial marijuana projects, North American business, natural sweetener raw materials and competition in the industry.

Data show that Rhein Biological is mainly engaged in the production and operation business of natural health products, and continues to focus on the field of plant functional ingredients. Plant extract is based on plants as raw materials, according to the purpose of the customer's use, and through the process of physical extraction and separation, the directional acquisition and one or more effective ingredients in the integrated plant or natural Chinese herbal medicine The product.

At present, Rhein Biological Corporation has successfully studied and developed more than 300 standardized plant extract products. The products include Luo Han Guo extract, sweet leaf chrysanthemum extraction, industrial marijuana extraction, tea extract, and other health skin care extracts , Red Scenery extract, Cedar Grass extract, Epimedium extract, etc.). The upstream of the industry mainly involves agriculture, and the downstream product application industry covers food, beverages, medicine, health products and cosmetics, animal feed and other industries.

In terms of market performance, Rhein's biological stock price rose by 34.79%this week, up to 7.62%as of today, at 13.56 yuan, with a total market value of 7.664 billion yuan.

In addition to Rhein Biology, HKUST Xunfei (002230.SZ) obtained a survey of 3 fund managers, including Li Xiaoxing, a subsidiary of Yinhua Fund, on June 30, 2022. Wait.

- END -